Deletion of Interferon Lambda Receptor Elucidates Susceptibility to the Murine Model of Biliary Atresia
Journal of Interferon & Cytokine Research · 2023
DOI: 10.1089/jir.2023.0046 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Interferon & Cytokine Research, 2023. Verfasst von Stephen J Hartman und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric and Thoracic Surgery, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA. Hauptthemen laut MEDLINE: Biliary Atresia, Cholestasis, Receptors, Interferon. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS.
Abstract (Originalsprache)
Biliary atresia (BA) is a life-threatening cholangiopathy occurring in infancy, the most common indication for pediatric liver transplantation. The etiology of BA remains unknown; however, a viral etiology has been proposed as multiple viruses have been detected in explants of infants afflicted with BA. In the murine model of BA, Rhesus rotavirus (RRV) infection of newborn BALB/c pups results in a cholangiopathy that mirrors human BA. Infected BALB/c pups experience 100% symptomatology and mortality, while C57BL/6 mice are asymptomatic. Interferon-λ (IFN-λ) is an epithelial cytokine that provides protection against viral infection. We demonstrated that IFN-λ is highly expressed in C57BL/6, leading to reduced RRV replication. RRV-infection of C57BL/6 IFN-λ receptor knockout (C57BL/6 IFN-λR KO) pups resulted in 90% developing obstructive symptoms and 45% mortality with a higher viral titer in bile ducts and profound periportal inflammation compared to C57BL/6. Histology revealed complete biliary obstruction in symptomatic C57BL/6 IFN-λR KO pups, while C57BL/6 ducts were patent. These findings suggest that IFN-λ is critical in preventing RRV replication. Deficiency in IFN-λ permits RRV infection, which triggers the inflammatory cascade causing biliary obstruction. Further IFN-λ study is warranted as it may play an important role in infant susceptibility to BA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric and Thoracic Surgery, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
- Southeast Poultry Research Laboratory, US National Poultry Research Center, United States Department of Agriculture (USDA-ARS), Athens, Georgia, USA.
ORCID-Profile: Stephen J Hartman
Förderung
- NIDDK NIH HHS
Zitieren
APA
Hartman, S. J., Weiss, M. A., Temple, H. M., Donnelly, B., Pasula, R., Poling, H. M., McNeal, M., Mohanty, S. K., & Tiao, G. M. (2023). Deletion of Interferon Lambda Receptor Elucidates Susceptibility to the Murine Model of Biliary Atresia. Journal of Interferon & Cytokine Research. https://doi.org/10.1089/jir.2023.0046
Vancouver
Hartman SJ, Weiss MA, Temple HM, Donnelly B, Pasula R, Poling HM, et al. Deletion of Interferon Lambda Receptor Elucidates Susceptibility to the Murine Model of Biliary Atresia. Journal of Interferon & Cytokine Research. 2023. doi:10.1089/jir.2023.0046
BibTeX
@article{Hartman2023,
author = {Hartman, Stephen J and Weiss, Madeleine A and Temple, Haley M and Donnelly, Bryan and Pasula, Rajamouli and Poling, Holly M and McNeal, Monica and Mohanty, Sujit K and Tiao, Greg M},
title = {Deletion of Interferon Lambda Receptor Elucidates Susceptibility to the Murine Model of Biliary Atresia},
journal = {Journal of Interferon & Cytokine Research},
year = {2023},
doi = {10.1089/jir.2023.0046}
}
EUVIMED